Citations (71)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Shun-bin Luo, Er-min Gu, Yu-ao Chen, Shi-chen Zhou, Chen Fan & Ren-ai Xu. (2022) Effect of quercetin on the pharmacokinetics of selexipag and its active metabolite in beagles. Pharmaceutical Biology 60:1, pages 1-8.
Read now
Read now
Nicholas J Connors, Maryann Mazer-Amirshahi, Sergey Motov & Hong K Kim. (2021) Relative Addictive Potential of Opioid Analgesic Agents. Pain Management 11:2, pages 201-215.
Read now
Read now
Kodye L. Abbott, Patrick C. Flannery, Kristina S. Gill, Dawn M. Boothe, Muralikrishnan Dhanasekaran, Sridhar Mani & Satyanarayana R. Pondugula. (2020) Adverse pharmacokinetic interactions between illicit substances and clinical drugs. Drug Metabolism Reviews 52:1, pages 44-65.
Read now
Read now
Francesca Toselli, Peter R. Dodd & Elizabeth M. J. Gillam. (2016) Emerging roles for brain drug-metabolizing cytochrome P450 enzymes in neuropsychiatric conditions and responses to drugs. Drug Metabolism Reviews 48:3, pages 379-404.
Read now
Read now
Deborah French. (2013) The Challenges of LC–MS/MS Analysis of Opiates and Opioids in Urine. Bioanalysis 5:22, pages 2803-2820.
Read now
Read now
Yin Cheong Wong, Shuai Qian & Zhong Zuo. (2012) Regioselective biotransformation of CNS drugs and its clinical impact on adverse drug reactions. Expert Opinion on Drug Metabolism & Toxicology 8:7, pages 833-854.
Read now
Read now
Markus R Meyer & Hans H Maurer. (2011) Absorption, Distribution, Metabolism and Excretion Pharmacogenomics of Drugs of Abuse. Pharmacogenomics 12:2, pages 215-233.
Read now
Read now
Robert J Balch & Andrea Trescot. (2010) Extended-release morphine sulfate in treatment of severe acute and chronic pain. Journal of Pain Research 3, pages 191-200.
Read now
Read now
Yiwen Gao, Duan Liu, Huijuan Wang, Juanli Zhu & Chao Chen. (2010) Functional characterization of five CYP2C8 variants and prediction of CYP2C8 genotype-dependent effects on in vitro and in vivo drug–drug interactions. Xenobiotica 40:7, pages 467-475.
Read now
Read now
Elizabeth B Daily & Christina L Aquilante. (2009) Cytochrome P450 2C8 Pharmacogenetics: A Review of Clinical Studies. Pharmacogenomics 10:9, pages 1489-1510.
Read now
Read now
Shu-Feng Zhou, Jun-Ping Liu & Balram Chowbay. (2009) Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metabolism Reviews 41:2, pages 89-295.
Read now
Read now
Articles from other publishers (60)
Julian Bickel, Nadine Aboutara, Hilke Jungen, Anne Szewczyk, Alexander Müller, Benjamin Ondruschka & Stefanie Iwersen-Bergmann. (2024) Morphine concentrations in fatalities after palliative treatment of acute burn injury. International Journal of Legal Medicine 138:3, pages 839-847.
Crossref
Crossref
Yasushi Yamazoe, Yoshiya Yamamura & Kouichi Yoshinari. (2024) Construction of a fused grid-based CYP2C8-Template system and the application. Drug Metabolism and Pharmacokinetics 55, pages 100492.
Crossref
Crossref
Shelby Coates, Keti Bardhi & Philip Lazarus. (2024) Cannabinoid-Induced Inhibition of Morphine Glucuronidation and the Potential for In Vivo Drug–Drug Interactions. Pharmaceutics 16:3, pages 418.
Crossref
Crossref
Shelby Coates & Philip Lazarus. (2023) Hydrocodone, Oxycodone, and Morphine Metabolism and Drug–Drug Interactions. Journal of Pharmacology and Experimental Therapeutics 387:2, pages 150-169.
Crossref
Crossref
Yoshiya Yamamura, Kouichi Yoshinari & Yasushi Yamazoe. (2023) Construction of a fused grid-based CYP2C19-Template system and the application. Drug Metabolism and Pharmacokinetics 48, pages 100481.
Crossref
Crossref
Tao Song, Xudong Zhang, Mao Ding, Alfonso Rodriguez-Paton, Shudong Wang & Gan Wang. (2022) DeepFusion: A deep learning based multi-scale feature fusion method for predicting drug-target interactions. Methods 204, pages 269-277.
Crossref
Crossref
Guyi Wang, Bing Xiao, Jiayi Deng, Linmei Gong, Yi Li, Jinxiu Li & Yanjun Zhong. (2022) The Role of Cytochrome P450 Enzymes in COVID-19 Pathogenesis and Therapy. Frontiers in Pharmacology 13.
Crossref
Crossref
Brooks T. McPhail, Chie Emoto, Dawn Butler, Tsuyoshi Fukuda, Henry Akinbi & Alexander A. Vinks. (2021) Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches. The Journal of Clinical Pharmacology 61:7, pages 857-870.
Crossref
Crossref
Alfred Francis Attah, Adeshola Adebayo Fagbemi, Olujide Olubiyi, Hannah Dada-Adegbola, Akinseinde Oluwadotun, Anthony Elujoba & Chinedum Peace Babalola. (2021) Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine With COVID-19 in Focus: A Nigerian Perspective. Frontiers in Pharmacology 12.
Crossref
Crossref
Zi-Ning Lei, Zhuo-Xun Wu, Shaowei Dong, Dong-Hua Yang, Litu Zhang, Zunfu Ke, Chang Zou & Zhe-Sheng Chen. (2020) Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19. Pharmacology & Therapeutics 216, pages 107672.
Crossref
Crossref
Kanecia O. ZimmermanSamantha H. DallefeldChristoph P. HornikKevin M. Watt. (2020) Sedative and Analgesic Pharmacokinetics During Pediatric ECMO. The Journal of Pediatric Pharmacology and Therapeutics 25:8, pages 675-688.
Crossref
Crossref
Ashley Singh, Clement Zai, Ayeshah G Mohiuddin & James L Kennedy. (2020) The pharmacogenetics of opioid treatment for pain management. Journal of Psychopharmacology 34:11, pages 1200-1209.
Crossref
Crossref
Robert Root-Bernstein, Beth Churchill & Miah Turke. (2020) Glutathione and Glutathione-Like Sequences of Opioid and Aminergic Receptors Bind Ascorbic Acid, Adrenergic and Opioid Drugs Mediating Antioxidant Function: Relevance for Anesthesia and Abuse. International Journal of Molecular Sciences 21:17, pages 6230.
Crossref
Crossref
Stephanie Basiliere & Sarah Kerrigan. (2020) CYP450-Mediated Metabolism of Mitragynine and Investigation of Metabolites in Human Urine. Journal of Analytical Toxicology 44:4, pages 301-313.
Crossref
Crossref
Eva Schrezenmeier & Thomas Dörner. (2020) Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nature Reviews Rheumatology 16:3, pages 155-166.
Crossref
Crossref
Tao Liu, Vijay Ivaturi & Jogarao Gobburu. (2019) Integrated Model to Describe Morphine Pharmacokinetics in Humans. The Journal of Clinical Pharmacology 59:8, pages 1070-1077.
Crossref
Crossref
Ricardo Jorge Dinis-Oliveira. (2019) Metabolism and metabolomics of opiates: A long way of forensic implications to unravel. Journal of Forensic and Legal Medicine 61, pages 128-140.
Crossref
Crossref
P. Nyssen, A. Mouithys-Mickalad, G. Minguet, E. Sauvage, J. Wouters, T. Franck & M. Hoebeke. (2018) Morphine, a potential inhibitor of myeloperoxidase activity. Biochimica et Biophysica Acta (BBA) - General Subjects 1862:10, pages 2236-2244.
Crossref
Crossref
Jessica Winborn, Donovan Haines & Sarah Kerrigan. (2018) In vitro metabolism of desomorphine. Forensic Science International 289, pages 140-149.
Crossref
Crossref
Sandeep T. Patil, Ron H. Bihovsky, Steven A. Smith, William Z. Potter & Valentino J. Stella. (2018) Novel prodrug PRX-P4-003, selectively activated by gut enzymes, may reduce the risk of iatrogenic addiction and abuse. Drug and Alcohol Dependence 186, pages 159-166.
Crossref
Crossref
Nadine Schaefer, Daniel Moj, Thorsten Lehr, Peter H. Schmidt & Frank Ramsthaler. (2017) The feasibility of physiologically based pharmacokinetic modeling in forensic medicine illustrated by the example of morphine. International Journal of Legal Medicine 132:2, pages 415-424.
Crossref
Crossref
Alexandra Maas, Burkhard Madea & Cornelius Hess. (2017) Confirmation of recent heroin abuse: Accepting the challenge. Drug Testing and Analysis 10:1, pages 54-71.
Crossref
Crossref
K. Sandy Pang, Qi Joy Yang & Keumhan Noh. (2017) Unequivocal evidence supporting the segregated flow intestinal model that discriminates intestine versus liver first‐pass removal with PBPK modeling. Biopharmaceutics & Drug Disposition 38:3, pages 231-250.
Crossref
Crossref
Q. J. Yang, J. Fan, S. Chen, L. Liu, H. Sun & K. S. Pang. (2016) Metabolite Kinetics: The Segregated Flow Model for Intestinal and Whole Body Physiologically Based Pharmacokinetic Modeling to Describe Intestinal and Hepatic Glucuronidation of Morphine in Rats In Vivo. Drug Metabolism and Disposition 44:7, pages 1123-1138.
Crossref
Crossref
Janne T. Backman, Anne M. Filppula, Mikko Niemi & Pertti J. Neuvonen. (2015) Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions. Pharmacological Reviews 68:1, pages 168-241.
Crossref
Crossref
Maria Andersson, Linda Björkhem‐Bergman, Lena Ekström, Lena Bergqvist, Hugo Lagercrantz, Anders Rane & Olof Beck. (2014) Detection of morphine‐3‐sulfate and morphine‐6‐sulfate in human urine and plasma, and formation in liver cytosol. Pharmacology Research & Perspectives 2:6.
Crossref
Crossref
Hong-Jaan Wang, Cheng-Huei Hsiong, Li-Heng Pao, Wen-Liang Chang, Li-Jie Zhang, Min-Jen Lin, Shung-Tai Ho, Pei-Wei Huang & Oliver Yoa-Pu Hu. (2013) New finding of nalbuphine metabolites in men: NMR spectroscopy and UPLC–MS/MS spectrometry assays in a pilot human study. Metabolomics 10:4, pages 709-718.
Crossref
Crossref
T.O. Lilius, V. Jokinen, M.S. Neuvonen, A.J. Väänänen, M. Niemi, P.V. Rauhala & E.A. Kalso. (2013) The mineralocorticoid receptor antagonist spironolactone enhances morphine antinociception. European Journal of Pain 18:3, pages 386-395.
Crossref
Crossref
Christina L. Aquilante, Mikko Niemi, Li Gong, Russ B. Altman & Teri E. Klein. (2013) PharmGKB summary. Pharmacogenetics and Genomics 23:12, pages 721-728.
Crossref
Crossref
Konrad MeissnerMichael J. AvramViktar Yermolenka, Amber M. Francis, Jane BloodEvan D. Kharasch. (2013) Cyclosporine-inhibitable Blood–Brain Barrier Drug Transport Influences Clinical Morphine Pharmacodynamics. Anesthesiology 119:4, pages 941-953.
Crossref
Crossref
Francesco Rua, Giovanna Di Nardo, Sheila J. Sadeghi & Gianfranco Gilardi. (2012)
Toward reduction in animal sacrifice for drugs: Molecular modeling of
Macaca fascicularis
P450 2C20 for virtual screening of
Homo sapiens
P450 2C8 substrates
. Biotechnology and Applied Biochemistry 59:6, pages 479-489.
Crossref
Crossref
Markus R. Meyer & Hans H. Maurer. 2012. Metabolism of Drugs and Other Xenobiotics. Metabolism of Drugs and Other Xenobiotics
429
463
.
Andrew A. Somogyi & Janet K. Coller. 2012. Metabolism of Drugs and Other Xenobiotics. Metabolism of Drugs and Other Xenobiotics
403
428
.
Pallabi Mitra, Jürgen Venitz, Yunyun Yuan, Yan Zhang & Phillip M. Gerk. (2011) Preclinical Disposition (In Vitro) of Novel μ-Opioid Receptor Selective Antagonists. Drug Metabolism and Disposition 39:9, pages 1589-1596.
Crossref
Crossref
Tomohiro Kaku, Nobuyuki Matsunaga, Akio Ojida, Toshimasa Tanaka, Takahito Hara, Masuo Yamaoka, Masami Kusaka & Akihiro Tasaka. (2011) 17,20-Lyase inhibitors. Part 4: Design, synthesis and structure–activity relationships of naphthylmethylimidazole derivatives as novel 17,20-lyase inhibitors. Bioorganic & Medicinal Chemistry 19:5, pages 1751-1770.
Crossref
Crossref
Sarah Küchler, Nadine B. Wolf, Sarah Heilmann, Günther Weindl, Jürgen Helfmann, Momin Mohd Yahya, Christoph Stein & Monika Schäfer-Korting. (2010) 3D-Wound healing model: Influence of morphine and solid lipid nanoparticles. Journal of Biotechnology 148:1, pages 24-30.
Crossref
Crossref
Howard S. Smith. (2009) Opioid Metabolism. Mayo Clinic Proceedings 84:7, pages 613-624.
Crossref
Crossref
Howard S. Smith. (2009) Opioid Metabolism. Mayo Clinic Proceedings 84:7, pages 613-624.
Crossref
Crossref
B. P. Sweeney & M. Grayling. (2009) Smoking and anaesthesia: the pharmacological implications. Anaesthesia 64:2, pages 179-186.
Crossref
Crossref
Steven Karch. 2008. Karch's Pathology of Drug Abuse, Fourth Edition. Karch's Pathology of Drug Abuse, Fourth Edition
367
374
.
Britta Bonn, Collen M. Masimirembwa, Yasmin Aristei & Ismael Zamora. (2008)
The Molecular Basis of CYP2D6-Mediated
N
-Dealkylation: Balance between Metabolic Clearance Routes and Enzyme Inhibition
. Drug Metabolism and Disposition 36:11, pages 2199-2210.
Crossref
Crossref
Harry Ahdieh. (2008) REGARDING CYP450 2D6 POOR METABOLIZERS. Pain Practice 8:4, pages 329-329.
Crossref
Crossref
Shinya Kasai, Masakazu Hayashida, Ichiro Sora & Kazutaka Ikeda. (2007) Candidate gene polymorphisms predicting individual sensitivity to opioids. Naunyn-Schmiedeberg's Archives of Pharmacology 377:4-6, pages 269-281.
Crossref
Crossref
Akash Khandelwal, Praveen M. Bahadduri, Cheng Chang, James E. Polli, Peter W. Swaan & Sean Ekins. (2007) Computational Models to Assign Biopharmaceutics Drug Disposition Classification from Molecular Structure. Pharmaceutical Research 24:12, pages 2249-2262.
Crossref
Crossref
Tímea Polgár, Dóra K. Menyhárd & György M. Keserű. (2007) Effective virtual screening protocol for CYP2C9 ligands using a screening site constructed from flurbiprofen and S-warfarin pockets. Journal of Computer-Aided Molecular Design 21:9, pages 539-548.
Crossref
Crossref
Amanda Jenkins. 2007. Pharmacokinetics and Pharmacodynamics of Abused Drugs. Pharmacokinetics and Pharmacodynamics of Abused Drugs
25
63
.
S Parikh, J-B Ouedraogo, J A Goldstein, P J Rosenthal & D L Kroetz. (2007) Amodiaquine Metabolism is Impaired by Common Polymorphisms in CYP2C8: Implications for Malaria Treatment in Africa. Clinical Pharmacology & Therapeutics 82:2, pages 197-203.
Crossref
Crossref
Olav Magnus S. Fredheim, Petter C. Borchgrevink, Pål Klepstad, Stein Kaasa & Ola Dale. (2012) Long term methadone for chronic pain: A pilot study of pharmacokinetic aspects. European Journal of Pain 11:6, pages 599-604.
Crossref
Crossref
F. Gagné, C. Blaise, C. André, C. Gagnon & M. Salazar. (2007) Neuroendocrine disruption and health effects in Elliptio complanata mussels exposed to aeration lagoons for wastewater treatment. Chemosphere 68:4, pages 731-743.
Crossref
Crossref
Amanda Jenkins. 2006. Drug Abuse Handbook, Second Edition. Drug Abuse Handbook, Second Edition
147
205
.
Shuso Takeda, Yurie Kitajima, Yuji Ishii, Yoshio Nishimura, Peter I. Mackenzie, Kazuta Oguri & Hideyuki Yamada. (2006) INHIBITION OF UDP-GLUCURONOSYLTRANSFERASE 2B7-CATALYZED MORPHINE GLUCURONIDATION BY KETOCONAZOLE: DUAL MECHANISMS INVOLVING A NOVEL NONCOMPETITIVE MODE. Drug Metabolism and Disposition 34:8, pages 1277-1282.
Crossref
Crossref
Hans H. Maurer, Christoph Sauer & Denis S. Theobald. (2006) Toxicokinetics of Drugs of Abuse: Current Knowledge of the Isoenzymes Involved in the Human Metabolism of Tetrahydrocannabinol, Cocaine, Heroin, Morphine, and Codeine. Therapeutic Drug Monitoring 28:3, pages 447-453.
Crossref
Crossref
B. P. Sweeney & J. Bromilow. (2006) Liver enzyme induction and inhibition: implications for anaesthesia. Anaesthesia 61:2, pages 159-177.
Crossref
Crossref
M. Ganzera, P. Schneider & H. Stuppner. (2006) Inhibitory effects of the essential oil of chamomile (Matricaria recutita L.) and its major constituents on human cytochrome P450 enzymes. Life Sciences 78:8, pages 856-861.
Crossref
Crossref
Shuso Takeda, Yuji Ishii, Megumi Iwanaga, Peter I. Mackenzie, Kiyoshi Nagata, Yasushi Yamazoe, Kazuta Oguri & Hideyuki Yamada. (2005) Modulation of UDP-Glucuronosyltransferase Function by Cytochrome P450: Evidence for the Alteration of UGT2B7-Catalyzed Glucuronidation of Morphine by CYP3A4. Molecular Pharmacology 67:3, pages 665-672.
Crossref
Crossref
Shuso Takeda, Yuji Ishii, Peter I. Mackenzie, Kiyoshi Nagata, Yasushi Yamazoe, Kazuta Oguri & Hideyuki Yamada. (2005) Modulation of UDP-Glucuronosyltransferase 2B7 Function by Cytochrome P450s in Vitro: Differential Effects of CYP1A2, CYP2C9 and CYP3A4. Biological and Pharmaceutical Bulletin 28:10, pages 2026-2027.
Crossref
Crossref
M. W. Hruska, J. A. Amico, T. Y. Langaee, R. E. Ferrell, S. M. Fitzgerald & R. F. Frye. (2004) The effect of trimethoprim on CYP2C8 mediated rosiglitazone metabolism in human liver microsomes and healthy subjects. British Journal of Clinical Pharmacology 59:1, pages 70-79.
Crossref
Crossref
Alan Wiseman. (2005) Elimination of major side effects due to ROS of therapeuticals through biotransformation control of the 57 cytochromes P450 isoenzymes. Medical Hypotheses 64:4, pages 802-805.
Crossref
Crossref
Radka Vaclavikova, Pavel Soucek, Lenka Svobodova, Pavel Anzenbacher, Petr Simek, F. Peter Guengerich & Ivan Gut. (2004) DIFFERENT IN VITRO METABOLISM OF PACLITAXEL AND DOCETAXEL IN HUMANS, RATS, PIGS, AND MINIPIGS. Drug Metabolism and Disposition 32:6, pages 666-674.
Crossref
Crossref
Toshimasa TanakaNaomi KamiguchiTeruaki OkudaYoshio Yamamoto. (2004) Characterization of the CYP2C8 Active Site by Homology Modeling. Chemical and Pharmaceutical Bulletin 52:7, pages 836-841.
Crossref
Crossref